Merck (MRK) Tops Q3 EPS by 4c; Lifts FY15 EPS Outlook

Merck (NYSE: MRK) reported Q3 EPS of $0.96, $0.04 better than the analyst estimate of $0.92. Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $10.11 billion.

Merck sees FY2015 EPS of $3.55-$3.60, versus prior guidance of $3.45-$3.55 and the consensus of $3.51.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• Nike (NKE) Tops Q1 EPS by 4c
• McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
• Evercore ISI Upgrades Legrand SA (LR:FP) (LGRDY) to Outperform